Pfizer's $25 support holds strong, with institutional buying signals and growth potential in oncology. Click here to read an ...
The sell-off might have to do with the convertible note pricing, while some speculated that it's a sign of investors' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback